Steven Cohen’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.6M Buy
+411,629
New +$2.46M ﹤0.01% 2257
2026
Q1
– Sell
-69,275
Closed -$247K – 4505
2025
Q4
$247K Buy
+69,275
New +$257K ﹤0.01% 3551
2023
Q3
– Sell
-14,147
Closed -$7.78K – 2878
2023
Q2
$7.78K Buy
+14,147
New +$7.48K ﹤0.01% 1940

Other funds holding STLN

Steven Cohen's STLN Position: Q3 2026 in Review

Steven Cohen opened a new position in Starling Oncology (STLN) in Q3 2026: 411,629 shares worth $2.6M. The stake represents ﹤0.01% of the portfolio and ranks #2257 among its holdings. This is a return to the name: Steven Cohen previously reported a position in STLN as recently as Q4 2025.

Steven Cohen first reported a position in STLN in Q2 2023 and has held it in 3 quarters since. 128 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Steven Cohen held 411,629 shares of Starling Oncology worth $2.6M as of Q3 2026.
  • Starling Oncology was a new Steven Cohen position in Q3 2026.
  • Starling Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2257 holding.
  • Steven Cohen first reported a position in Starling Oncology in Q2 2023 and has held it in 3 quarters since.
  • 128 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.